Isomorphic Labs Signs Lucrative Drug Discovery Deals with Eli Lilly and Novartis

Isomorphic Labs, a spin-out from DeepMind, has recently entered into two significant drug discovery collaborations with pharmaceutical giants Eli Lilly and Novartis. These strategic partnerships aim to leverage the power of artificial intelligence (AI) to expedite drug discovery processes and potentially yield substantial profits for the company. With an upfront payment totaling $82.5 million... source: https://www.cryptopolitan.com/isomorphic-labs-signs-drug-discovery-with-eli-lilly-and-novartis/